Recombinant Immunotoxins for the Treatment of Chemoresistant Hematologic Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|23|2652-2664

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.23, 2009-08, pp. : 2652-2664

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunotoxins in the Treatment of Hematologic Malignancies

By  

Current Drug Targets, Vol. 7, Iss. 10, 2006-01 ,pp. : 1301-1311

Bentham Science Publishers

Access to resources Recommend Favorite

Entinostat for treatment of solid tumors and hematologic malignancies

By Knipstein Jeffrey   Gore Lia  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 10, 2011-10 ,pp. : 1455-1467

Informa Healthcare

Access to resources Recommend Favorite

JAK2 inhibition for the treatment of hematologic and solid malignancies

By Harry Brian L   Eckhardt S. Gail   Jimeno Antonio  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 5, 2012-05 ,pp. : 637-655

Informa Healthcare

Access to resources Recommend Favorite

The Role of Apoptosis in Cancer Development and Treatment: Focusing on the Development and Treatment of Hematologic Malignancies

By  

Current Pharmaceutical Design, Vol. 16, Iss. 1, 2010-01 ,pp. : 11-33

Bentham Science Publishers

Access to resources Recommend Favorite

Approaches to Optimize Gene Therapy for the Treatment of Hematologic Malignancies: Overcoming the Obstacles

By  

Current Gene Therapy, Vol. 16, Iss. 6, 2017-03 ,pp. : 390-400

Bentham Science Publishers

Access to resources Recommend Favorite